carfilzomib + elotuzumab + dexamethasone
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for carfilzomib + elotuzumab + dexamethasone, covering 2023-09-26 to 2023-09-26. Get the full timeline:
Most recent: Clinical Trial Update: Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines [Phase 2]